EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Eliminating Medication Copayments for Low-Income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial

David J T Campbell iD, Chad Mitchell, Brenda R Hemmelgarn, Marcello Tonelli iD, Peter Faris iD, Jianguo Zhang, Ross T Tsuyuki iD, Jane Fletcher iD, Flora Au, Scott Klarenbach, Derek V Exner, Braden J Manns iD und 1 weitere

Circulation · 16.05.2023 · 147 (20) · 1505-1514

DOI: 10.1161/circulationaha.123.064188 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Circulation, erschienen am 16.05.2023. Verfasst von David J T Campbell und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Community Health Sciences (D.J.T.C., M.T., P.F., J.Z., J.F., D.V.E., B.J.M.), Cumming School of Medicine, University of Calgary, Canada. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Myocardial Infarction, Stroke. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Canadian Institutes of Health Research, Alberta Innovates, University of Calgary, Clinical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

One in eight people with heart disease has poor medication adherence that, in part, is related to copayment costs. This study tested whether eliminating copayments for high-value medications among low-income older adults at high cardiovascular risk would improve clinical outcomes.

Methods

This randomized 2×2 factorial trial studied 2 distinct interventions in Alberta, Canada: eliminating copayments for high-value preventive medications and a self-management education and support program (reported separately). The findings for the first intervention, which waived the usual 30% copayment on 15 medication classes commonly used to reduce cardiovascular events, compared with usual copayment, is reported here. The primary outcome was the composite of death, myocardial infarction, stroke, coronary revascularization, and cardiovascular-related hospitalizations over a 3-year follow-up. Rates of the primary outcome and its components were compared using negative binomial regression. Secondary outcomes included quality of life (Euroqol 5-dimension index score), medication adherence, and overall health care costs.

Results

A total of 4761 individuals were randomized and followed for a median of 36 months. There was no evidence of statistical interaction ( P =0.99) or of a synergistic effect between the 2 interventions in the factorial trial with respect to the primary outcome, which allowed us to evaluate the effect of each intervention separately. The rate of the primary outcome was not reduced by copayment elimination, (521 versus 533 events, incidence rate ratio 0.84 [95% CI, 0.66–1.07], P =0.162). The incidence rate ratio for nonfatal myocardial infarction, nonfatal stroke, and cardiovascular death (0.97 [95% CI, 0.67–1.39]), death (0.94 [95% CI, 0.80 to 1.11]), and cardiovascular-related hospitalizations (0.78 [95% CI, 0.57 to 1.06]) did not differ between groups. No significant between-group changes in quality of life over time were observed (mean difference, 0.012 [95% CI, –0.006 to 0.030], P =0.19). The proportion of participants who were adherent to statins was 0.72 versus 0.69 for the copayment elimination versus usual copayment groups, respectively (mean difference, 0.03 [95% CI, 0.006–0.06], P =0.016). Overall adjusted health care costs did not differ ($3575 [95% CI, –605 to 7168], P =0.098).

Conclusions

In low-income adults at high cardiovascular risk, eliminating copayments (average, $35/mo) did not improve clinical outcomes or reduce health care costs, despite a modest improvement in adherence to medications. Registration: URL: https://www.clinicaltrials.gov ; Unique identifier: NCT02579655.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesMyocardial InfarctionStrokeHumansAgedQuality of LifeRisk FactorsAlberta

Stichwörter der Autor:innen

cardiovascular diseasecopayment eliminationmedication insurancerandomized trial

Autor:innen und Institutionen

  • Department of Community Health Sciences (D.J.T.C., M.T., P.F., J.Z., J.F., D.V.E., B.J.M.), Cumming School of Medicine, University of Calgary, Canada.
  • Department of Medicine (D.J.T.C., M.T., F.A., B.J.M.), Department of Cardiac Sciences (D.J.T.C., D.V.E.), Cumming School of Medicine, University of Calgary, Canada.
  • Libin Cardiovascular Institute (D.J.T.C., M.T., D.V.E., B.J.M.), Cumming School of Medicine, University of Calgary, Canada.
  • O'Brien Institute of Public Health (D.J.T.C., M.T., B.J.M.), Cumming School of Medicine, University of Calgary, Canada.
  • Pharmaceutical Branch, Alberta Health, Government of Alberta, Edmonton, Canada (C.M.).
  • Department of Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada (B.R.H., R.T.T., S.K.).

ORCID-Profile: David J T Campbell, Marcello Tonelli, Peter Faris, Ross T Tsuyuki, Jane Fletcher, Braden J Manns

Förderung

  • Canadian Institutes of Health Research
  • Alberta Innovates
  • University of Calgary, Clinical Research Fund

Zitieren

APA

Campbell, D. J. T., Mitchell, C., Hemmelgarn, B. R., Tonelli, M., Faris, P., Zhang, J., Tsuyuki, R. T., Fletcher, J., Au, F., Klarenbach, S., Exner, D. V., Manns, B. J., & Interdisciplinary Chronic Disease Collaboration (2023). Eliminating Medication Copayments for Low-Income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial. Circulation, 147(20), 1505-1514. https://doi.org/10.1161/circulationaha.123.064188

Vancouver

Campbell DJT, Mitchell C, Hemmelgarn BR, Tonelli M, Faris P, Zhang J, et al. Eliminating Medication Copayments for Low-Income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial. Circulation. 2023;147(20):1505-1514. doi:10.1161/circulationaha.123.064188

BibTeX
@article{Campbell2023,
  author = {Campbell, David J T and Mitchell, Chad and Hemmelgarn, Brenda R and Tonelli, Marcello and Faris, Peter and Zhang, Jianguo and Tsuyuki, Ross T and Fletcher, Jane and Au, Flora and Klarenbach, Scott and Exner, Derek V and Manns, Braden J and Interdisciplinary Chronic Disease Collaboration, Interdisciplinary Chronic Disease Collaboration},
  title = {Eliminating Medication Copayments for Low-Income Older Adults at High Cardiovascular Risk: A Randomized Controlled Trial},
  journal = {Circulation},
  year = {2023},
  volume = {147},
  number = {20},
  pages = {1505--1514},
  doi = {10.1161/circulationaha.123.064188}
}
Kostenlos starten →